Maximum quantity allowed is 999
请选择数量
CAS RN: 608141-41-9 | 產品號碼: A3669
| 產品號碼 | A3669 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__2__2H__2__4N__2O__7S = 460.50 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Refrigerated (0-10°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Heat Sensitive |
| 包裝和容器 | 1G-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 608141-41-9 |
| Reaxys-RN | 12446985 |
| MDL編號 | MFCD18782607 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Volumetric Analysis) | min. 98.0 % |
| Melting point | 155.0 to 159.0 °C |
| Specific rotation | +26.0 to +30.0 deg(C=2, CHCl3) |
| NMR | confirm to structure |
性質
| 熔點 | 157 °C |
| 水溶性 | Insoluble |
| 溶解性（可溶於） | Tetrahydrofuran, Acetone, dichloromethane |
| 溶解性（不溶於） | Toluene |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H361 : Suspected of damaging fertility or the unborn child. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相關法規
運輸資料
| HS編碼* | 2930.90-900 |
Application
Apremilast: A cAMP Phosphodiesterase-4 Inhibitor
Phosphodiesterase-4 (PDE4), primarily found in immune, epithelial and brain cells, is an intracellular non-receptor enzyme that modulates inflammation and epithelial integrity. PDE4 participates in the regulation of the inflammatory response by degrading adenosine 3', 5'-cyclicmonophosphate (cAMP) [A2381, A2112 (Na salt)], a key second messenger. Inhibition of PDE4 increases intracellular cAMP levels, resulting in a decrease in pro-inflammatory mediators and an increase in anti-inflammatory mediators. Apremilast is an oral, small molecule inhibitor of PDE4 that is specific for cAMP. PDE4 inhibition results in increased intracellular cAMP levels. In clinical use, apremilast is approved for the treatment of inflammatory diseases, psoriasis and psoriatic arthritis. (The product is for research purpose only.)
References
- Discovery of (S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast Apremilast ), a Potent and Orally Active Phosphodiesterase 4 and Tumor Necrosis Factor-α Inhibitor
- Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
- Apremilast mechanism of action and application to psoriasis and psoriatic arthritis (a review)
- Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。